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Antimicrobial resistance has increased rapidly in Brazil and worldwide during the past few
years, giving rise to a growing necessity for antimicrobial resistance surveillance programs.
These programs have been instituted in order to monitor bacterial resistance in various regions,
and to guide empirical antimicrobial therapy. We evaluated the use of molecular typing in
multicenter surveillance programs. We also studied the dissemination modes of selected resistance
profiles. Antimicrobial susceptibility to various antimicrobial agents was evaluated by the reference
broth microdilution method. Bacterial isolates with selected susceptibility patterns were
characterized by pulsed field-gel electrophoresis (PFGE). A total of 119 Gram-negative bacteria
were molecularly typed, including 22 imipenem-resistant Pseudomonas aeruginosa, 26 ESBL-
producing Escherichia coli, 27 cefoxitin-resistant-ESBL-producing Klebsiella pneumoniae, 33
Enterobacter spp., 8 Citrobacter spp., and 3 S. marcescens isolates resistant to ceftazidime. The
isolates were from clinically apparent bacteremia of patients hospitalized in medical centers
located in 13 cities of 11 Brazilian states. Our molecular typing results revealed a great genetic
diversity among isolates of the same species. However, some major PFGE patterns were found in
more than one isolate. All repeated PFGE patterns were detected in only 2 isolates, which were
isolated within the same institutions or in different medical centers. We conclude that the ability
to characterize organisms phenotypically and genotypically is a powerful epidemiologic tool and
it provides unique information that is very important for multicenter surveillance programs.
Key Words: Molecular typing, pulsed-field gel electrophoresis, antimicrobial resistance,
carbapenem-resistant Pseudomonas aeruginosa, clonal dissemination, Sentinela Program.
Antimicrobial resistance has become an important
problem worldwide [1]. Bacterial resistance to
antimicrobial agents has been emerging and rapidly
disseminating among many nosocomial and community-
acquired pathogens [2]. Control of antimicrobial
resistance has become a strategic priority for hospitals
and health care providers on a global scale. As part of
this effort, there are now several major programs that
have been organized to conduct surveillance for
antimicrobial resistance on both national and
international levels [3-5].
Most surveillance programs use a conventional
antimicrobial susceptibility testing method to determine
phenotypic profiles. Although useful as a screening
method for detecting certain resistance profiles and for
selecting potentially useful therapeutic agents,
conventional antimicrobial susceptibility testing methods
are insensitive tools for tracing the spread of individual
strains within a hospital or region. On the other hand,
molecular typing methods provide powerful tools to
track bacterial strains. Molecular typing contributes to
the evaluation of nosocomial infection outbreaks,
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recurrent infection and clonal dissemination of specific
pathogens [6,7]. Some surveillance programs have
incorporated molecular typing techniques as a means
of providing additional information, to detect and
evaluate the mode of dissemination of multi-drug
resistant (MDR) pathogens [8].
When the isolates are genotypically distinct, clustering
may occur due to excessive drug pressure, which may
favor resistant phenotypes within a group of unrelated
isolates. On the other hand, the finding of isolates with
identical or similar molecular typing in distinct patients
indicates clonal dissemination. The dissemination of MDR
strains between patients within medical centers has been
extensively documented. In addition, reports of the
dissemination of MDR bacterial clones between medical
centers have recently become more common [9-11].
The Sentinela Antimicrobial Resistance Surveillance
(Sentinela) Program is one of the surveillance programs
in place in Brazil [12]. We characterized isolates
selected from the Sentinela Program based on their
susceptibility to antimicrobial agents and on their DNA
macrorestriction profiles, in order to evaluate and
understand the clonal dissemination of resistant strains
within and among hospitals in Brazil.
Materials and Methods
Bacterial isolates. One hundred nineteen isolates were
selected among 835 Gram-negative bacteria samples
collected from 36 Brazilian hospitals as part of the
Sentinela Program. The isolates were collected from
blood stream infections from April to November of
1998. The hospitals were located in 13 cities from 11
states. Only one isolate per patient was included in the
program. The isolates were identified at the participant
center and they were sent to the Laboratório Especial
de Microbiologia Clínica (LEMC) from the Infectious
Diseases Division of the Federal University of São
Paulo (UNIFESP/EPM), São Paulo, Brazil, where they
were subcultured on nutrient agar slants and stored for
future complementary tests.
Susceptibility testing. The antimicrobial susceptibilities
of isolates to 20 compounds were evaluated by broth
microdilution using MicroScan Dried Gram Negative
MIC/Combo panels (Dade-Behring, Sacramento,
USA), according to the National Committee for Clinical
Laboratory Standards (NCCLS) instructions [13]. A
standard suspension of the organisms was used to
inoculate the panels, which were incubated at 35°C
for a minimum of 16 hours. The minimum inhibitory
concentration (MIC) was determined according to the
lowest antimicrobial concentration showing inhibition
of growth. The following antimicrobial agents were
tested: cefoxitin, ceftizoxime, ceftazidime, cefotaxime,
ceftriaxone, cefoperazone, cefpodoxime, cefepime,
imipenem, meropenem, ampicillin/sulbactam,
ciprofloxacin, aztreonam, amoxicillin/clavulanate,
ticarcillin/clavulanate, mezlocillin, sparfloxacin,
piperacillin/tazobactam, netilmicin, and azlocollin.
Quality control measures were implemented by testing
with Staphylococcus aureus ATCC 29213,
Escherichia coli ATCC 25922, and Pseudomonas
aeruginosa ATCC 27853, periodically during the
study. The breakpoint interpretive criteria used were
those established by the NCCLS [14].
Klebsiella pneumoniae and E. coli isolates with
increased MICs (≥ 2µg/ml) for ceftazidime and/or
ceftriaxone and/or aztreonam were considered as
possible extended-spectrum beta-lactamase (ESBL)
producing strains according to NCCLS criteria [13].
The ESBL phenotype was confirmed by using the
ESBL Etest strips (AB Biodisk, Solna, Sweden),
which evaluate the variation of either ceftazidime or
cefotaxime MICs when clavulanic acid is added at
2µg/ml [15].
Molecular typing. The isolates were selected to be
evaluated by pulsed-field gel electrophoresis (PFGE),
based on their susceptibilities to selected antimicrobial
agents. Thus, P. aeruginosa with MIC ≥ 16µg/ml to
imipenem (22 isolates), ESBL-producing Escherichia
coli (26 isolates), ESBL producing Klebsiella
pneumoniae with cefoxitin MIC ≥ 16µg/ml (27
isolates), and samples of Enterobacter cloacae (22
isolates), Enterobacter aerogenes (11 isolates),
Citrobacter spp. (8 isolates), and Serratia marcescens
(3 isolates) with MIC ≥ 32µg/ml to ceftazidime, which
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are probably producers of chromosomally derepressed
ampC beta-lactamases, were characterized by
macrorestriction analysis of chromosomal DNA using
the pulsed field-gel electrophoresis (PFGE) technique
[16]. Genomic DNA inserts were digested at 37°C,
during an overnight period (12 to 16hs), with 10U/ml
of SpeI enzyme (New England Biolabs, Inc., Beverly,
MA, USA). Electrophoresis was performed in a
CHEF-DRIII apparatus (Bio-Rad, Richmond, CA,
USA), under the following conditions: 0.5 TBE, 1%
agarose, 13°C, 200V. The electrophoresis ran for 21hs,
with the switch interval ramped appropriately for the
species being tested [16]. Photographs of ethidium
bromide-stained gels were examined visually. Isolates
were considered distinct strains whenever there were
3 or more different fragments or bands in the
comparisons between PFGE profiles. Isolates were
considered similar (subtypes of a major PFGE pattern)
whenever there were 1 to 3 band differences between
PFGE patterns. Isolates with the same PFGE profile
were considered indistinguishable [16]. Major PFGE
patterns were identified by a capital letter, while their
subtypes were denominated with the same capital letter
followed by a subscribed number (A1 and A2 for
example).
Results
In general, molecular typing revealed considerable
genetic diversity among isolates of the same species.
However, some major PFGE patterns were found in
more than one isolate. Isolates sharing identical or
similar PFGE patterns are shown in Table 1. Repeated
PFGE patterns were never detected in more than 2
isolates, which were isolated within the same institutions
or from distinct medical centers.
Seventeen different PFGE patterns were observed
among the 19 imipenem-resistant P. aeruginosa strains.
Two major PFGE patterns were observed in more than
one sample (two samples each) (Figure 1). Two isolates
with an identical PFGE pattern (called “B”) were
isolated in different institutions located in the same city
(São Paulo), whereas samples with similar patterns (I1
and I2) were isolated from the same hospital.
Similarly, considerable genetic diversity was
observed among both ESBL-producing K.
pneumoniae and cefoxitin-resistant-ESBL-producing
E. coli. Three PFGE patterns were shared by more
than one K. pneumoniae isolate and two PFGE
patterns were shared by more than one E. coli isolate.
Each of these repeated PFGE patterns was detected
in two isolates from different institutions. In addition,
three of these repeated patterns were shared by isolates
from institutions located in different cities.
Three PFGE patterns were shared by more than
one E. cloacae isolate and two were shared among E.
aerogenes isolates (Table 1). Two pairs of clonally
related isolates were collected from patients
hospitalized in a medical center located in São Paulo
city, whereas the other repeated pattern (two samples)
was found in samples isolated from different cities (São
Paulo and Curitiba, Figure 2). Both pairs of E.
aerogenes isolates sharing identical PFGE patterns
were collected from patients hospitalized in cities
located 700 to 1000 km apart (Table 1 and Figure 3).
Similarly, the clonally related Citrobacter spp. strains
were isolated in Juiz de Fora and São Paulo, which
are located approximately 400 km from each other
(Table 1 and Figure 4).
Discussion
The molecular typing characterization of
microorganisms to provide evidence of genetic
relatedness is frequently used by physicians,
microbiologists, and epidemiologists as an aid in the
epidemiological investigation of infectious diseases [7].
A need to determine the relatedness of organisms may
arise during an outbreak investigation in which a cluster
of infections due to organisms of the same species and
similar antimicrobial resistance profiles  is identified, in
order to determine clonal spread within a
microenvironment, and to determine the source of
infection [6].
On the other hand, epidemiological surveillance
conducted over time requires the monitoring of clonal
spread, and determination of the prevalence of strains
within a population to monitor the emergence and
Antimicrobial Resistance Among Gram-negative Rods
BJID 2003; 7 (December) 363
Table 1. Hospital location of isolates with repeated major PFGE patterns
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Organism Medical center #/ Location PFGE Pattern
isolate #
Pseudomonas aeruginosa 1/90069 São Paulo B
4/96073 São Paulo B
8/103073 Campinas I1
8/103051 Campinas I2
E. coli 9/115090 Florianópolis G
16/115002 Porto Alegre G
14/102002 Porto Alegre L
15/102039 Porto Alegre L
Klebsiella pneumoniae 2/101056 São Paulo B
3/111056 São Paulo B
2/101082 São Paulo C
15/111078 Porto Alegre C
3/111042 São Paulo F
10/121042 Rio de Janeiro F
Enterobacter cloacae 7/97073 São Paulo B
11/97091 Curitiba B
1/97004 São Paulo C
1/97054 São Paulo C
1/97068 São Paulo E
1/97063 São Paulo E
Enterobacter aerogenes 3/106061 São Paulo D
9/106005 Florianópolis D
8/97048 Campinas G
16/97071 Porto Alegre G
Citrobacter spp. 5/95069 Juiz de Fora D1
3/109044 São Paulo D2
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Figure 1. Pulsed-field gel electrophoresis patterns of imipenem-resistant Pseudomonas aeruginosa isolates
(lane – PFGE pattern): 1 – A; 2 - B, 3 – C, 4 – D, 5 – E, 6 – F; 7 – B; 8 – G, 9 – H, 10 – I1, 11 – I2, 12 – J, 13
– K, 14 – L, 15 – M, 16 – Z (control). Identical strains (PFGE type B) are shown in lanes 2 and 7, similar PFGE
patterns I1 and I2 are shown in lanes 10 and 11, and the remaining lanes represent strains with unique PFGE
patterns. λ - lamdba marker.
Antimicrobial Resistance Among Gram-negative Rods
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Medical center 1 2 2 2 3 4 4 5 7 8 8 8 10 10 10 2
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Figure 2. Pulsed-field gel electrophoresis patterns of Enterobacter cloacae isolates (lane – PFGE pattern): 1 –
A; 2 – B; 3 – C; 4 – C; 5 – D; 6 – E; 7 – E; 8 – F; 9 – Z (control). Identical strains are shown in lanes 3 and 4
(PFGE pattern C) and in lanes 6 and 7 (PFGE pattern E), respectively. The remaining lanes represent strains with
unique PFGE patterns. λ - lambda marker.
Antimicrobial Resistance Among Gram-negative Rods
λ 1 2 3 4 5 6 7 8 9
Medical center 1 7 1 1 1 1 1 2 2
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Figure 3. Pulsed-field gel electrophoresis patterns of Enterobacter aerogenes (lane – PFGE patterns): 1 – A; 2
– B; 3 – C; 4 – D; 5 – D; 6 – E; 7 – F; 8 – G; 9 – G; 10 – H. Identical strains (PFGE type D and type G) are
shown in lanes 4 and 5 and 8 and 9, respectively (D e G). The remaining lanes represent strains with unique PFGE
patterns. λ - lambda marker.
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Figure 4. Pulsed-field gel electrophoresis patterns of Citrobacter spp. (lane – PFGE pattern): 1 – A; 2 – B; 3 –
C; 4 – D1; 5 – E; 6 – F; 7 - D2; 8 – Z (control S). Similar strains (PFGE patterns D1 and D2) are shown in lanes
4 and 7. The remaining lanes represent strains with unique PFGE patterns λ - lambda marker.
Antimicrobial Resistance Among Gram-negative Rods
λ 1 2 3 4 5 6 7 8
Medical center 1 1 3 5 14 8 3 2
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dissemination of specific pathogens, especially MDR
bacteria [10,17]. In any surveillance program the
phenotypic characterization of microorganisms and the
identification of clusters of isolates of certain species
and of resistance phenotypes is the primary role of the
microbiology laboratory. Consequently, the surveillance
laboratory serves as an “early warning system,” alerting
the submitting institution of a potential problem with
resistant organisms in the patient population [8]. In most
of the existing antimicrobial resistance surveillance
programs, whether they are local, regional, national,
or international in scope, the process does not go much
beyond phenotypic characterization and reporting.
However, to be of maximum service to individual
hospitals, regions, or countries, the surveillance
laboratory must go one step further and provide a rapid
assessment of microbial clonality by molecular typing
[8]. The Sentinela Program is one of the rare examples
of regional surveillance programs that use molecular
typing characterization of microorganisms to evaluate
the dissemination of resistance mechanisms. We have
clearly demonstrated clonal dissemination of MDR
strains among Brazilian hospitals.
The rapid emergence and dissemination of drug
resistance among bacteria has provoked a call for control
of these pathogens as a strategic priority for hospitals
on a global scale [18], and the finding of clones within a
phenotypically identical cluster may have a direct impact
on the method of intervention [19]. If the clustered isolates
are genotypically different, then the clustering may be
due to chance alone, to grouping together of several highly
susceptible patients, or to excessive drug pressure,
resulting in the selection of a resistant phenotype within
a group of unrelated isolates. Clonal dissemination of a
resistant strain illustrates the need for more extensive
investigations to identify the mechanism of spread and
for renewed attention to infection control efforts.
The identification of an endemic resistance problem
that is due to the occurrence of multiple clusters of
organisms requires a composite approach involving
antimicrobial restrictions and focused use of barrier
infection-control precautions [19]. Determination of
the resistance genotype provides insight into the
mechanism of resistance and it may be necessary in
order to understand whether a resistance problem is
due to the transmission of resistance genes from
organism to organism (controlled by antimicrobial
restrictions) or through the transmission of a single
resistant strain (controlled by infection-control
precautions). Identification of a subpopulation of
organisms that are first-step mutants in a multistep
pathway leading to high-level resistance (e.g.,
fluoroquinolone resistance) may trigger strategies that
can both prevent the development of high-level
resistance and improve therapy overall [20].
On a broader scale, identification of resistant clones
with extensive geographic distributions may provide
insight into strain virulence and pathogenesis and also
may result in public health interventions, such as
vaccination and antimicrobial restrictions aimed at
reducing the spread of the pathogen and the resistance
problem.  These considerations provide the rationale
for the comprehensive molecular typing program that
is an integral part of the SENTRY Antimicrobial
Surveillance Program [8]. Each year hundreds of
organisms are molecularly characterized, the information
is reported to the individual participating centers, and
the aggregated data are used to help describe the
epidemiology of MDR pathogens [10,11,21,22].
Our results are an overview of molecular typing
characterization of organisms obtained during the
course of an antimicrobial resistance surveillance
program. In order to provide a comprehensive
molecular characterization service, the organisms
themselves must be readily available. This illustrates
the need for a central reference laboratory to serve as
a repository of organisms, as well as a standardized
source for all microbial characterizations. The ability
to utilize molecular typing methods to follow the
geographic spread of specific clones provides new
information and offers additional opportunities for
research that may clarify issues of pathogenesis and
epidemiology.
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